October JAAD: Routine rescreening for latent tuberculosis has low utility in patients with chronic immune- mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study

Release Date:

Anthony P. Fernandez, MD, FAAD and Urmi Khanna, MD interviewed by Brad Glick, DO, MPH, FAAD

October JAAD: Routine rescreening for latent tuberculosis has low utility in patients with chronic immune- mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study

Title
October JAAD: Routine rescreening for latent tuberculosis has low utility in patients with chronic immune- mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study
Copyright
Release Date

flashback